9 results  1 of 1 

1 Performance Validation of Three Scoring Systems for the Prediction of Thrombotic Microangiopathy Due to Severe ADAMTS13 Deficiency and the Response to Therapeutic Plasma Exchange: First Study in Korea
Sang Hyuk Park, Hyun-Ki Kim, Joseph Jeong, Seon-Ho Lee, Yoo Jin Lee, Yoo Jin Kim, Jae-Cheol Jo, Ji-Hun Lim
Ann Lab Med.2023;43(5):485-492.   Published online 2023 April 21     DOI: http://dx.doi.org/10.3343/alm.2023.43.5.485
      
2 Recent advances in the management of immune-mediated thrombotic thrombocytopenic purpura
Sung Hwa Bae, Sung-Hyun Kim, Soo-Mee Bang
Blood Res.2022;57(S1):37-43.   Published online 2022 April 30     DOI: http://dx.doi.org/10.5045/br.2022.2022005
      
3 Prognostic utility of ADAMTS13 activity for the atypical hemolytic uremic syndrome (aHUS) and comparison of complement serology between aHUS and thrombotic thrombocytopenic purpura
Jisu Oh, Doyeun Oh, Seon Ju Lee, Jeong Oh Kim, Nam Keun Kim, So Young Chong, Ji Young Huh, Ross I. Baker,
Blood Res.2019;54(3):218-228.   Published online 2019 September 25     DOI: http://dx.doi.org/10.5045/br.2019.54.3.218
      
4 Clinical characteristics and outcomes of thrombotic microangiopathy in Malaysia
Yee Yee Yap, Jameela Sathar, Kian Boon Law, Putri Astina Binti Zulkurnain, Syed Carlo Edmund, Kian Meng Chang, Ross Baker
Blood Res.2018;53(2):130-137.   Published online 2018 June 25     DOI: http://dx.doi.org/10.5045/br.2018.53.2.130
      
5 Effect of Vitamin D Status on Von Willebrand Factor and ADAMTS13 in Diabetic Patients on Chronic Hemodialysis
Keren Cohen-Hagai, Gloria Rashid, Yael Einbinder, Meital Ohana, Sydney Benchetrit, Tali Zitman-Gal
Ann Lab Med.2017;37(2):155-158.   Published online 2016 December 20     DOI: http://dx.doi.org/10.3343/alm.2017.37.2.155
      
6 ADAMTS13 Gene Mutations in Children with Hemolytic Uremic Syndrome
Hyoung Soo Choi, Hae Il Cheong, Nam Keun Kim, Doyeun Oh, Hye Won Park
Yonsei Med J.2011;52(3):530-534.   Published online 2011 April 6     DOI: http://dx.doi.org/10.3349/ymj.2011.52.3.530
      
7 A Case Report of Rituximab Therapy for Recurrent Thrombotic Thrombocytopenia Purpura
Seungbum Lee, Je-Hwan Lee, Yunsuk Choi, Ji Hee Yu, Yoon Hee Chun, Won Jung Choi, Sang-Su Jung
Korean J Hematol.2009;44(3):193-197.   Published online 2009 September 20     DOI: http://dx.doi.org/10.5045/kjh.2009.44.3.193
   
8 Clinical Significance of von Willebrand Factor-Cleaving Protease (ADAMTS13) Deficiency in Patients with Sepsis-Induced Disseminated Intravascular Coagulation
Young Keun Kim, Jongwook Lee, Kyung-A Lee, Hee Uk Kwon
Infect Chemother.2009;41(2):78-81.   Published online 2009 April 30     DOI: http://dx.doi.org/10.3947/ic.2009.41.2.78
      
9 Investigation of von Willebrand Factor Gene Mutations in Korean von Willebrand Disease Patients
Jaewoo Song, Jong Rak Choi, Kyung Soon Song
Korean J Lab Med.2007;27(3):169-176.   Published online 2007 February 10     DOI: http://dx.doi.org/10.3343/kjlm.2007.27.3.169
   

 1 of 1